Suven Pharmaceuticals Ltd

Next 500 2023
+ 2 More
+ 2 More
OVERVIEW
FINANCIALS

Featured In Fortune India Ranking

Next 500 India
Next 500 India
#242(2023)#239(2022)#291(2021)
#242(2023)#239(2022)#291(2021)

Financial Data 2024

Revenue
1,064
(INR Cr)
Net Operating Income
1,051
(INR Cr)
Assets
2,126
(INR Cr)
Profit
300
(INR Cr)
Net Worth
2,051
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS202420232022202120202019
Revenue
(INR Cr)
1064
-24.4%
1408
-7.0%
1514
39.4%
1086
19.2%
911
127.9%
400
-
Net Operating Income
(INR Cr)
1051
-21.56%
1340
1.52%
1320
30.75%
1010
21.10%
834
120.68%
378
0.00%
Profit
(INR Cr)
300
-27.0%
411
-9.4%
454
25.2%
362
14.3%
317
190.1%
109
-
Assets
(INR Cr)
2126
17.2%
1814
11.1%
1633
22.8%
1330
28.0%
1039
53.1%
679
-
Net Worth
(INR Cr)
2051
18.2%
1735
13.6%
1527
29.3%
1181
39.8%
845
46.3%
578
0.0%
Employee Cost
(INR Cr)
136
14.9%
118
17.7%
100
31.8%
76
17.1%
65
119.7%
30
-
Interest Cost
(INR Cr)
713912233
Cash & Bank Balance
(INR Cr)
516847101413
Total Debt
(INR Cr)
65709714318683

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS202420232022202120202019
Profit As % Of Revenues 28.2%29.2%30.0%33.4%34.8%27.3%
Profit As % Of Assets 14.1%22.7%27.8%27.2%30.5%16.1%
Profit As % Of Networth 14.6%23.7%29.7%30.7%37.5%18.9%
Interest Cost to EBITDA % 1.8%2.2%1.5%2.6%6.0%1.6%
Debt to Equity Ratio 0.030.040.060.120.220.14
RONW 14.1%25.2%29.8%35.8%44.6%18.9%
ROCE 18.7%33.2%40.6%40.5%49.8%23.7%